This past weekend, I had the opportunity to attend and discuss RNA exon editing at VISIONS 2024. The energy at this meeting was awesome. To recap:
-We heard from and honored leaders working tirelessly for the past few decades to tackle retinal diseases.
-Blind or low-vision individuals shared personal stories of how they have overcome challenges to live incredibly successful and fulfilling lives.
- Scientists, engineers, and clinicians reviewed the basic cellular and molecular mechanisms that regulate vision, expanding knowledge of IRD genetics, new preclinical model systems, new technologies including AI and digital accessibility tools, and emerging therapies.
-As researchers and drug developers, we can learn from the model of engagement and resilience of those impacted with blindness or low vision and their families
At Ascidian, we are advancing ACDN-01 in an active Phase 1/2 clinical study (STELLAR) with the goal of slowing down or stopping the damage to the retina experienced by people with Stargardt disease and other ABCA4 retinopathies by targeting the genetic origin of the disease.
As a society, we can do more. I encourage everyone in our day-to-day lives to find ways to help enable and promote accessibility to individuals living with disabilities.
#Accessibility #DisabilityInclusion #foundationfightingblindness
#TwoBlindBrothers #VISIONS2024 #RNAExonEditing
https://lnkd.in/erkQ6xwq
More than anything, we appreciate connecting with the communities we aim to serve. Thank you Foundation Fighting Blindness for hosting #VISIONS24 and giving us an opportunity to share the latest updates on our science with individuals and families affected by blinding diseases. #RNAExonEditing #StargardtDisease
Robert Bell
Helping Science & Technology companies find top talent through personalized recruitment solutions.
3moIt's wonderful to see Ascidian Therapeutics engaging directly with the community at #VISIONS24 to share advancements in RNA exon editing for Stargardt Disease. Connecting science with those affected by blinding diseases is crucial for progress and support. Keep shining a light on innovation and impact! 🌟 #RecruitsLab #BioJobsLab